394 related articles for article (PubMed ID: 27428748)
21. TET2 and DNMT3A mutations and exceptional response to 4'-thio-2'-deoxycytidine in human solid tumor models.
Yang SX; Hollingshead M; Rubinstein L; Nguyen D; Larenjeira ABA; Kinders RJ; Difilippantonio M; Doroshow JH
J Hematol Oncol; 2021 May; 14(1):83. PubMed ID: 34039392
[TBL] [Abstract][Full Text] [Related]
22. Deletion of Tet2 in mice leads to dysregulated hematopoietic stem cells and subsequent development of myeloid malignancies.
Li Z; Cai X; Cai CL; Wang J; Zhang W; Petersen BE; Yang FC; Xu M
Blood; 2011 Oct; 118(17):4509-18. PubMed ID: 21803851
[TBL] [Abstract][Full Text] [Related]
23. Loss of Dnmt3a and endogenous Kras(G12D/+) cooperate to regulate hematopoietic stem and progenitor cell functions in leukemogenesis.
Chang YI; You X; Kong G; Ranheim EA; Wang J; Du J; Liu Y; Zhou Y; Ryu MJ; Zhang J
Leukemia; 2015 Sep; 29(9):1847-56. PubMed ID: 25801914
[TBL] [Abstract][Full Text] [Related]
24. TET2 Loss Dysregulates the Behavior of Bone Marrow Mesenchymal Stromal Cells and Accelerates Tet2
Li R; Zhou Y; Cao Z; Liu L; Wang J; Chen Z; Xing W; Chen S; Bai J; Yuan W; Cheng T; Xu M; Yang FC; Zhao Z
Stem Cell Reports; 2018 Jan; 10(1):166-179. PubMed ID: 29290626
[TBL] [Abstract][Full Text] [Related]
25. Cytokine-Regulated Phosphorylation and Activation of TET2 by JAK2 in Hematopoiesis.
Jeong JJ; Gu X; Nie J; Sundaravel S; Liu H; Kuo WL; Bhagat TD; Pradhan K; Cao J; Nischal S; McGraw KL; Bhattacharyya S; Bishop MR; Artz A; Thirman MJ; Moliterno A; Ji P; Levine RL; Godley LA; Steidl U; Bieker JJ; List AF; Saunthararajah Y; He C; Verma A; Wickrema A
Cancer Discov; 2019 Jun; 9(6):778-795. PubMed ID: 30944118
[TBL] [Abstract][Full Text] [Related]
26. SCL expression at critical points in human hematopoietic lineage commitment.
Zhang Y; Payne KJ; Zhu Y; Price MA; Parrish YK; Zielinska E; Barsky LW; Crooks GM
Stem Cells; 2005; 23(6):852-60. PubMed ID: 15917481
[TBL] [Abstract][Full Text] [Related]
27. TET2 is essential for survival and hematopoietic stem cell homeostasis.
Shide K; Kameda T; Shimoda H; Yamaji T; Abe H; Kamiunten A; Sekine M; Hidaka T; Katayose K; Kubuki Y; Yamamoto S; Miike T; Iwakiri H; Hasuike S; Nagata K; Marutsuka K; Iwama A; Matsuda T; Kitanaka A; Shimoda K
Leukemia; 2012 Oct; 26(10):2216-23. PubMed ID: 22469782
[TBL] [Abstract][Full Text] [Related]
28. Plzf drives MLL-fusion-mediated leukemogenesis specifically in long-term hematopoietic stem cells.
Ono R; Masuya M; Nakajima H; Enomoto Y; Miyata E; Nakamura A; Ishii S; Suzuki K; Shibata-Minoshima F; Katayama N; Kitamura T; Nosaka T
Blood; 2013 Aug; 122(7):1271-83. PubMed ID: 23838347
[TBL] [Abstract][Full Text] [Related]
29. TET2: A cornerstone in normal and malignant hematopoiesis.
Kunimoto H; Nakajima H
Cancer Sci; 2021 Jan; 112(1):31-40. PubMed ID: 33048426
[TBL] [Abstract][Full Text] [Related]
30. Non-catalytic Roles of Tet2 Are Essential to Regulate Hematopoietic Stem and Progenitor Cell Homeostasis.
Ito K; Lee J; Chrysanthou S; Zhao Y; Josephs K; Sato H; Teruya-Feldstein J; Zheng D; Dawlaty MM; Ito K
Cell Rep; 2019 Sep; 28(10):2480-2490.e4. PubMed ID: 31484061
[TBL] [Abstract][Full Text] [Related]
31. Robust hematopoietic progenitor cell commitment in the presence of a conflicting cue.
Shah NA; Levesque MJ; Raj A; Sarkar CA
J Cell Sci; 2015 Aug; 128(16):3009-17. PubMed ID: 26159733
[TBL] [Abstract][Full Text] [Related]
32. DNA methylation disruption reshapes the hematopoietic differentiation landscape.
Izzo F; Lee SC; Poran A; Chaligne R; Gaiti F; Gross B; Murali RR; Deochand SD; Ang C; Jones PW; Nam AS; Kim KT; Kothen-Hill S; Schulman RC; Ki M; Lhoumaud P; Skok JA; Viny AD; Levine RL; Kenigsberg E; Abdel-Wahab O; Landau DA
Nat Genet; 2020 Apr; 52(4):378-387. PubMed ID: 32203468
[TBL] [Abstract][Full Text] [Related]
33. DNMT1 in
Li SY; Park J; Guan Y; Chung K; Shrestha R; Palmer MB; Susztak K
J Am Soc Nephrol; 2019 Apr; 30(4):594-609. PubMed ID: 30850438
[TBL] [Abstract][Full Text] [Related]
34. Oncogenic N-Ras and Tet2 haploinsufficiency collaborate to dysregulate hematopoietic stem and progenitor cells.
Jin X; Qin T; Zhao M; Bailey N; Liu L; Yang K; Ng V; Higashimoto T; Coolon R; Ney G; Figueroa ME; Li Q
Blood Adv; 2018 Jun; 2(11):1259-1271. PubMed ID: 29866713
[TBL] [Abstract][Full Text] [Related]
35. TET2 binding to enhancers facilitates transcription factor recruitment in hematopoietic cells.
Rasmussen KD; Berest I; Keβler S; Nishimura K; Simón-Carrasco L; Vassiliou GS; Pedersen MT; Christensen J; Zaugg JB; Helin K
Genome Res; 2019 Apr; 29(4):564-575. PubMed ID: 30796038
[TBL] [Abstract][Full Text] [Related]
36. Stem cell leukemia protein directs hematopoietic stem cell fate.
Kunisato A; Chiba S; Saito T; Kumano K; Nakagami-Yamaguchi E; Yamaguchi T; Hirai H
Blood; 2004 May; 103(9):3336-41. PubMed ID: 14726394
[TBL] [Abstract][Full Text] [Related]
37. The H3K4 methyltransferase Setd1b is essential for hematopoietic stem and progenitor cell homeostasis in mice.
Schmidt K; Zhang Q; Tasdogan A; Petzold A; Dahl A; Arneth BM; Slany R; Fehling HJ; Kranz A; Stewart AF; Anastassiadis K
Elife; 2018 Jun; 7():. PubMed ID: 29916805
[TBL] [Abstract][Full Text] [Related]
38. DNA methylation protects hematopoietic stem cell multipotency from myeloerythroid restriction.
Bröske AM; Vockentanz L; Kharazi S; Huska MR; Mancini E; Scheller M; Kuhl C; Enns A; Prinz M; Jaenisch R; Nerlov C; Leutz A; Andrade-Navarro MA; Jacobsen SE; Rosenbauer F
Nat Genet; 2009 Nov; 41(11):1207-15. PubMed ID: 19801979
[TBL] [Abstract][Full Text] [Related]
39. Myeloid disorders arise in Dnmt3a-null marrow.
Delwel R
Blood; 2015 Jan; 125(4):585-6. PubMed ID: 25614634
[No Abstract] [Full Text] [Related]
40. Epigenetic silencing of TET2 and TET3 induces an EMT-like process in melanoma.
Gong F; Guo Y; Niu Y; Jin J; Zhang X; Shi X; Zhang L; Li R; Chen L; Ma RZ
Oncotarget; 2017 Jan; 8(1):315-328. PubMed ID: 27852070
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
